InvestorsHub Logo
icon url

Phantom Lord

09/25/19 5:00 PM

#28586 RE: goldpaths #28585

100% agree. Marker's safety profile is far superior and that alone should count for a lot. Add to it the significantly lower cost with similar efficacy it's pretty much a no brainer which therapy patients would prefer.